biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Company codeBTMD
Company nameBiote Corp
IPO dateMar 02, 2021
Founded at2020
CEOMr. Bret Christensen
Number of employees217
Security typeOrdinary Share
Fiscal year-endMar 02
Address1875 W. Walnut Hill Ln #100
CityIRVING
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code75038
Phone19724869346
Websitehttps://haymakeracquisition.com/
Company codeBTMD
IPO dateMar 02, 2021
Founded at2020
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data